|
PVLA Palvella Therapeutics Inc 1583648 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-21,870,000.00 |
| Balance Sheet |
|
Current Assets
|
$253,028,000.00 |
|
Assets
|
$253,510,000.00 |
|
Current Liabilities
|
$11,947,000.00 |
|
Liabilities
|
$36,643,000.00 |
|
Equity
|
$216,867,000.00 |
|
Shares Out
|
14395705.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,709,000.00 |
|
Investing Cash Flow
|
$-62,472,000.00 |
| Market Analysis |
Market Cap
|
$2,052,539,618.90 |
|
Price
|
$142.58 |
|
BVPS
|
15.06 |
|
PB
|
9.47 |
|
EPS
|
-1.52 |
|
FCF
|
$-23,709,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-3.71 |
|
|
2026-05-07 |
-1.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.86 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-11 |
-1.03 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PVLA documents filed with the SEC.
PVLA Filings
Clear
